Vontobel Holding Ltd. Has $2.18 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Vontobel Holding Ltd. decreased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.5% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 27,065 shares of the company's stock after selling 3,860 shares during the quarter. Vontobel Holding Ltd.'s holdings in GE HealthCare Technologies were worth $2,184,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Rovin Capital UT ADV acquired a new stake in GE HealthCare Technologies during the 1st quarter worth about $506,000. Mather Group LLC. boosted its holdings in shares of GE HealthCare Technologies by 40.5% during the first quarter. Mather Group LLC. now owns 2,777 shares of the company's stock worth $224,000 after purchasing an additional 800 shares during the period. CHURCHILL MANAGEMENT Corp boosted its holdings in shares of GE HealthCare Technologies by 5.0% during the first quarter. CHURCHILL MANAGEMENT Corp now owns 112,750 shares of the company's stock worth $9,100,000 after purchasing an additional 5,323 shares during the period. J.Safra Asset Management Corp boosted its holdings in shares of GE HealthCare Technologies by 76.3% during the first quarter. J.Safra Asset Management Corp now owns 2,920 shares of the company's stock worth $236,000 after purchasing an additional 1,264 shares during the period. Finally, Spinnaker Trust boosted its holdings in shares of GE HealthCare Technologies by 0.5% during the first quarter. Spinnaker Trust now owns 46,333 shares of the company's stock worth $3,740,000 after purchasing an additional 217 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on GEHC shares. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. The Goldman Sachs Group decreased their price target on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Evercore ISI decreased their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a report on Thursday, May 1st. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and reduced their price target for the company from $74.00 to $73.00 in a report on Monday, May 5th. Finally, Morgan Stanley reduced their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $88.27.

GE HealthCare Technologies Stock Performance

GEHC traded down $1.46 on Monday, hitting $74.61. The company had a trading volume of 3,528,309 shares, compared to its average volume of 3,523,785. The company's fifty day moving average price is $71.85 and its 200 day moving average price is $77.44. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.98 and a quick ratio of 0.76. The stock has a market cap of $34.16 billion, a price-to-earnings ratio of 15.71, a price-to-earnings-growth ratio of 2.56 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. The firm had revenue of $4.78 billion during the quarter, compared to analyst estimates of $4.66 billion. During the same period in the previous year, the company earned $0.90 EPS. The company's revenue for the quarter was up 2.7% on a year-over-year basis. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies declared that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 25th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.19%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.95%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.